Lime Therapeutics

Lime Therapeutics is hiring! We are looking for an exceptionally talented PhD Scientist – Target Validation and Translational Drug Discovery. The ideal candidate will help us bring game-changing treatments to patients, by taking ownership of research programs and being a team player within our ambitious group. Are you the missing puzzle piece? If so, apply to join one of New York City's most exciting biotech companies! Please share this posting with anyone who might be interested. Note that we are not accepting external recruiters at this time.

Allow us to share with you the joy of our recent investment in Lime Therapeutics 🔬 – US-based biotech startup developing a game-changing drug discovery platform. Using an ultrasensitive lipid detection technology, the platform is able to target conditions such as cancer, metabolic disorders, and neurodegenerative diseases. Founded by a team with expertise in immunology, nanosensor technologies, and drug discovery, Lime Therapeutics has established relevant partnerships with pharmaceutical companies. 🤝 Huge congrats to the core team | Shardule Shah, PhD, MBA | Prakrit Jena | Daniel Heller | Mariluz Soula, PhD | on their progress up to date and looking forward to watching their future path 🚀 For more info see the link to a full article in comments. #investment #startup #biotech #lipidmetabolism #lipidbiology #lipiddysfunction #cancersucks #stopcancer #drugdiscovery

Kicking off 2024’s Industry Insights on Research and Innovation Seminar Series with a fantastic talk! We are very grateful to Dr. Shardule Shah, PhD, MBA and Dr. Prakrit Jena for coming to NYU and sharing Lime Therapeutics’ promising science and story. Our trainees, faculty, and clinicians particularly enjoyed hearing their tips and tricks for building a biotech. #IIRIS_series #research #innovation #science  #development #startups #biotech

Lime Therapeutics is proud to announce that we are starting a collaboration with the Novo Nordisk #BioInnovationHub through its Co-Creation Greenhouse Program. Through this collaboration, we will combine Novo Nordisk’s deep disease biology understanding with our expertise in real-time lipidomics. By leveraging our breakthrough lipid flux monitoring platform and data science capabilities, we will explore new therapeutic opportunities to improve efferocytosis in metabolic-dysfunction-associated steatohepatitis (MASH) and cardiometabolic disorders such as atherosclerosis. We look forward to working alongside Uli Stilz and Novo Nordisk’s Bio Innovation Hub team to apply our understanding of lipid monitoring while collaborating to uncover novel pharmacology that can potentially make a difference in the lives of people living with these conditions. #lipids #novonordisk #limetherapeutics #collaboration #cardiometabolism #atherosclerosis #mash #liverdisease

Lime Therapeutics is hiring! We are looking for a talented research associate to join our incredible scientific team to make breakthrough discoveries in cancer, metabolic diseases, and neurodegenerative disorders. If interested, please apply through the job posting below (no candidate DMs or recruiters, please). We appreciate you sharing this post amongst your network! ***EDIT*** - Please use this updated link here for the job posting - https://lnkd.in/eVmaM6zT

Lime Therapeutics is thrilled to announce that Dr. Mariluz Soula will be joining our team! Mariluz received her PhD from Rockefeller University and had a prolific graduate school career, including multiple first-author publications in the Nature family of journals (with more to come!). She was also the recipient of two highly competitive fellowships - HHMI Gilliam Fellowship and Women and Science Fellowship. Mariluz will be working at our Biolabs@NYULangone headquarters and will focus on advancing Lime's therapeutic pipeline in cancer and other diseases of lipid biology. Please join us in welcoming Mariluz! h/t to Trebla Talent for connecting Lime with Mariluz.

Attending BIO 2023? Click below to send Lime Therapeutics a meeting request in the BIO partnering system! We are open to meeting a variety of partners with a focus on Seed/Series A investors and pharma/biotech collaborators.  https://lnkd.in/eiiQSyJC #biotech #pharma #BIO2023